Guerbet SA (GBT.PA)
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide.
8.09+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-60.0%
The outlook
Guerbet SA currently reads as leaning bearish based on underperform — 3.7 avg of 3 analysts, below its 50- & 200-day averages, 4% of the way from its 52-week low to high, avg target +4% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusUnderperform — 3.7 avg of 3 analysts
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Price targetAvg target +4% vs current price
Analyst price target
~12-month · 3 analysts8.43average target+4.2% vs now
Now 8.09
Low 8.00High 9.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$101.5M
52-wk high
23.10
52-wk low
7.43
50-day avg
9.35
200-day avg
12.08
Trailing P/E
—